ACUTE CHEST SYNDROME Dr.Padma Gadde Dr. Dora Alvarez.

ACUTE CHEST SYNDROME

Dr.Padma GaddeDr. Dora Alvarez

ACUTE CHEST SYNDROME

“Acute chest syndrome" (ACS) broadly describes a disease

leading cause of death second most common cause of

hospitalization in patients with sickle cell disease

ACUTE CHEST SYNDROME Its rapid clinical course, with or

without fever, is characterized by chest pain, cough, progressive anemia, hypoxemia, and the presence of new pulmonary infiltrates on chest radiographs

Learning Objectives To identify the causes of acute chest

syndrome (ACS) in patients with sickle cell disease

To understand the pathophysiology of ACS

To recognize elements that are important in appropriate management of ACS

ACUTE CHEST SYNDROME The approach to diagnosis, monitoring, and

treatment requires

(1) recognition of the complication,

(2) correction, if possible, of inciting factors,

(3) maintenance of euvolemia,

(4) pain control, and

(5) use of transfusions and

(6) administration of oxygen, if needed.

ACUTE CHEST SYNDROMERisk factors

Younger age Homozygous sickle cell or sickle cell-beta°

thalassemia genotype Winter months Fever

ACUTE CHEST SYNDROMERisk factors

Surgery Avascular necrosis of bone Previous pulmonary events High hemoglobin levels High steady-state leukocyte counts Low fetal hemoglobin concentration

Pathophysiology

The pathogenesis of parenchymal lung infiltrates in ACS is incompletely understood.

Pulmonary infiltrates may result from either one process or a combination of several interacting processes, which may include atelectasis, infection, fat embolism, thromboembolism and, most commonly, in situ microvascular occlusion within

the pulmonary vasculature by sickled erythrocytes

Pathophysiology

The importance of nonembolic microvascular occlusion in causing ACS is demonstrated by findings on thin-cut computed tomographic scans: Arterioles and venules are either absent or diminished in number, and ground-glass opacities appear in a mosaic, patchy, or multifocal distribution

pathophysiology Fat embolism from bone marrow

necrosis seems to be an important and often unrecognized cause of ACS

pathophysiology Patients with pulmonary fat embolism are

more likely than others to have severe bone and chest pain, changes in mental status, and a prolonged hospital course.

A complete blood cell count in these patients shows more severe anemia and thrombocytopenia than in patients without pulmonary fat embolism, and chest radiographs reveal more multilobar infiltrates

pathophysiology sPLA2 liberates free fatty acids from

phospholipids. Measurement of secretory phospholipase A2

(sPLA2) levels may be helpful, because they

have recently been found to be elevated in patients with sickle cell disease and ACS from pulmonary fat embolism

pathophysiology An early rise in these levels precedes the

development of ACS and thus may be a useful marker in predicting its occurrence.

Furthermore, sPLA2 levels correlate with

disease severity.

Mechanisms of hypoxemia

Hypoventilation due to Direct chest-wall splinting from either rib

and sternal infarctions or abdominal crisis

Excessive sedation from narcotic analgesics, leading to decreased oxygen exchange


Ventilation-perfusion mismatch possibly caused by diseases that underlie or result from acute chest syndrome

Pneumonia Mucous plugging Aspiration Bronchospasm Pulmonary hypertension Cor pulmonale


Impaired oxygen diffusion from repetitive episodes of acute chest syndrome that ultimately result in restrictive lung disease (2,3)

Evaluation

ACS is more severe in adolescents and adults than in children.

Patients most commonly present with shortness of breath, chills, and pleuritic chest pain, but no fever

Evaluation

In some cases, physical signs of disease are delayed and are first noted during hospitalization.

Evaluation These include chest-wall tenderness secondary to rib

infarction. dullness to percussion caused by

pleural effusion. and auscultatory rales from pulmonary

consolidation.

Evaluation

Results of laboratory studies may show anemia with thrombocytopenia or thrombocytosis, leukocytosis, and evidence of hemolysis,

including elevated LDH bilirubin levels

EvaluationFindings on chest radiographs,

although not pathognomonic, include patchy lower-lobe involvement in a

segmental, lobar, or multilobar distribution, with or without pleural effusion.

Correlation between the extent of consolidation found on chest radiographs and the severity of hypoxemia is poor

Evaluation

The presence of bilateral pulmonary infiltrates, however, identifies a subset of patients who are more likely to have serious illness.

Their clinical course is characterized by tachycardia, protracted hypoxemia, longer duration of fever, and a greater fall in hemoglobin levels

Diagnostic tests for acute chest syndrome Sputum analysis for Gram's stain Blood cultures Chest radiographs Thin-cut computed tomographic scan of

chest Serial measurement of arterial blood gases Ultrasound or impedance plethysmography Bone scan Flexible bronchoscopy with

bronchoalveolar lavage

Management of acute chest syndrome

in patients with sickle cell disease Identify and treat all underlying

precipitating factors Maintain adequate oxygenation,

improve oxygen-carrying capacity, and improve tissue oxygen deliveryAdminister supplemental oxygen to maintain PaO2 in 70-100 mm Hg range

Management of acute chest syndrome in

patients with sickle cell disease

Give simple or exchange transfusion to enhance oxygen capacity or reduce hemoglobin S concentration to reverse episodes

For severe respiratory failure, use mechanical ventilation with positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP

Management of acute chest syndrome in patients with SSD

Prevent further alveolar collapse by using incentive spirometry, CPAP, and PEEP

Maintain adequate fluid volumeGive hypotonic saline (D5W or 5%

dextrose in 0.25% normal saline) to maintain normovolemic state


Control painGive adequate amounts of narcotic analgesics to alleviate pain, avoiding hypoventilation from excessive sedation

Nonsteroidal anti-inflammatory medications (if not contraindicated by underlying peptic ulcer or renal disease)

Morphine sulfate, 0.1-0.15 mg/kg every 3-4 hours intravenously, through fixed scheduling or patient-controlled analgesia


Treat underlying infectionProvide empirical coverage for community-acquired pneumonia, pending results from other studies; use second- or third-generation cephalosporin or selected beta-lactam/beta-lactamase inhibitor in combination with macrolide

Prescribe bronchodilatorUse albuterol (Airet, Proventil, Ventolin) through metered-dose inhaler or nebulizer


Fluid administrationIf the patient is unable to consume fluids orally, 5% dextrose in water or 5% dextrose in 0.25% normal saline solution should be administered intravenously to maintain euvolemia once any existing volume deficits have been corrected.


Dehydration must be remedied, because it can result in increased plasma osmolarity and intracellular dehydration of red blood cells.

Under those conditions, erythrocytes are more likely to sickle. Hypotonic saline solutions are used because free water enters the relatively hypertonic red blood cells.

This process causes osmotic swelling, decreased mean corpuscular hemoglobin concentration and, consequently, a reduced tendency for sickling.


Decisions regarding transfusion are best guided by the patient's clinical condition.

Simple transfusion is indicated for patients with mild to moderate ACS; the goal is a hemoglobin value of 10 g/dL

Exchange transfusions should be reserved for severe crises, when it is important to decrease the hemoglobin S concentration rapidly.

Unlike simple transfusions, exchange transfusions avoid the problems related to increased blood volume and viscosity. It is suggested that a PaO2 of less than 60 mm Hg, clinical deterioration, or a worsening condition seen on chest radiographs should prompt exchange transfusion.


The goal is to reduce the hemoglobin S concentration to 20% to 30% and the hematocrit to 30% (5). Patients with recurrent episodes of ACS may also benefit from regular exchange transfusions to maintain the hemoglobin S concentration below 30%.

ACUTE CHEST SYNDROME Dr.Padma Gadde Dr. Dora Alvarez.

Documents

Transcript of ACUTE CHEST SYNDROME Dr.Padma Gadde Dr. Dora Alvarez.